These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32463473)

  • 1. Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma.
    Zhang K; Shao CX; Zhu JD; Lv XL; Tu CY; Jiang C; Shang MJ
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32463473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer.
    Wang X; Zhang H; Bai M; Ning T; Ge S; Deng T; Liu R; Zhang L; Ying G; Ba Y
    Mol Ther; 2018 Mar; 26(3):774-783. PubMed ID: 29456019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lncRNA KCNQ1OT1 on autophagy and drug resistance of hepatocellular carcinoma cells by targeting miR-338-3p.
    Zhong W; Dai Q; Huang Q
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):191-196. PubMed ID: 32538770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway.
    Lou G; Chen L; Xia C; Wang W; Qi J; Li A; Zhao L; Chen Z; Zheng M; Liu Y
    J Exp Clin Cancer Res; 2020 Jan; 39(1):4. PubMed ID: 31898515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM).
    Fan X; Zhou S; Zheng M; Deng X; Yi Y; Huang T
    Biomed Pharmacother; 2017 Apr; 88():507-514. PubMed ID: 28126676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1).
    Yang Y; Shi L; Zhang D; Wu D; An Y; Zhang Y; Chen X
    Bioengineered; 2021 Dec; 12(1):6713-6723. PubMed ID: 34519634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
    Fu X; Liu M; Qu S; Ma J; Zhang Y; Shi T; Wen H; Yang Y; Wang S; Wang J; Nan K; Yao Y; Tian T
    J Exp Clin Cancer Res; 2018 Mar; 37(1):52. PubMed ID: 29530052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
    Qin X; Yu S; Zhou L; Shi M; Hu Y; Xu X; Shen B; Liu S; Yan D; Feng J
    Int J Nanomedicine; 2017; 12():3721-3733. PubMed ID: 28553110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
    Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
    J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes secreted by M2 macrophages promote cancer stemness of hepatocellular carcinoma via the miR-27a-3p/TXNIP pathways.
    Li W; Xin X; Li X; Geng J; Sun Y
    Int Immunopharmacol; 2021 Dec; 101(Pt A):107585. PubMed ID: 34601333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.
    Lou G; Song X; Yang F; Wu S; Wang J; Chen Z; Liu Y
    J Hematol Oncol; 2015 Oct; 8():122. PubMed ID: 26514126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L
    Cancer Res; 2010 Jun; 70(12):5184-93. PubMed ID: 20501828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cell-derived exosomes block malignant behaviors of hepatocellular carcinoma stem cells through a lncRNA C5orf66-AS1/microRNA-127-3p/DUSP1/ERK axis.
    Gu H; Yan C; Wan H; Wu L; Liu J; Zhu Z; Gao D
    Hum Cell; 2021 Nov; 34(6):1812-1829. PubMed ID: 34431063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
    PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of
    Liu Z; Dang C; Xing E; Zhao M; Shi L; Sun J
    DNA Cell Biol; 2019 Nov; 38(11):1366-1373. PubMed ID: 31633393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin resistance and malignant behaviors of lung cancer cells are promoted by circ_0002360 via targeting miR-6751-3p to regulate the expression of ZNF300.
    Ding L; Li L; Tang Z
    Thorac Cancer; 2022 Apr; 13(7):986-996. PubMed ID: 35166026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.